New Jersey Proposes Tough New Rules For HMOs

17 February 1997

In the USA, New Jersey has instituted tough new regulations for healthmaintenance organizations, which the state's Health Commissioners believe make up the most comprehensive consumer bill in the country.

The new rules require HMOs to make public any financial incentives they offer doctors to withhold care, and also prohibit them from limiting what doctors can tell patients about treatment options, including expensive ones not covered by insurance. New Jersey is also setting up an independent review panel for consumers to appeal against any decisions by HMOs to curtail or deny care.

Rules Not Binding, But Expected To Be Adhered To While the panel's recommendations would be non-binding, state health officials and consumer groups feel that HMOs would abide by the rulings in most cases. The new rules cover all those whose primary care physician is in the state, even if the person works in another state.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight